- Pharmaceutical companies are adopting AI for clinical data gathering, product promotion, and prototyping.
- Pharmaceutical companies are adopting AI for clinical data gathering, product promotion, and prototyping.
- Pharmaceutical companies are adopting AI for clinical data gathering, product promotion, and prototyping.
- Pharmaceutical companies are adopting AI for clinical data gathering, product promotion, and prototyping.
Council negotiates with developer Catalyst regarding project inclusion.
2 reports, 2 independent
Updated Jun 5
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Council negotiates with developer Catalyst regarding project inclusion.
Who's involved
What this event is mainly aboutKeep exploring
Part of
Pharmaceutical companies are adopting AI for clinical data gathering, product promotion, and prototyping.Also in this story
- CRO Partner and NetraMark have formed a partnership to utilize artificial intelligence for the analysis of clinical trial data.
- HubRx AI integrates with leading Large Language Models (LLMs) to streamline prescription hub services.
- Recursion Pharmaceuticals, Merck KGaA, and Tempus expanded collaborations to leverage multimodal datasets and launch AI models for drug discovery.
- Every Cure and Predictive Oncology Inc. formed a strategic collaboration to use AI for drug repurposing.
The entities involved
-
Catalyst
non-profit based in New York